Our inability to detect PHD3 promoter DNA methylation in primary human prostate tumors was surprising, however our results are supported by a recent study by Huang et al. [38], who screened 168 invasive breast carcinomas and did not find evidence of PHD3 DNA methylation using melting curve analysis of bisulfite converted DNA. This evidence concerns the gene EGLN3 and prostate neoplasm.